EVEROLIMUS
| Brand name | AFINITOR |
|---|---|
| Active ingredient | EVEROLIMUS |
| Strength | 10MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9006224 | July 2028 | use U-1681 |
| 8410131*PED | May 2026 | — |
| 8410131 | November 2025 | use U-1368 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.